TADA2A-NLK Fusion FISH Probe
The TADA2A-NLK Fusion FISH Probe is used to confirm a fusion of the TADA2A and NLK genes. The fusion of the TADA2A and NLK genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TADA2A-NLK-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TADA2A-NLK-20-AQAQ | 20 (40 μL) | 200 μL |
|
TADA2A Gene Summary
Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. The protein encoded by this gene is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. Several alternatively spliced transcript variants encoding different isoforms of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2009]
Gene Name: Transcriptional Adaptor 2A
Chromosome: CHR17: 35766976 -35837226
Locus: 17q12
NLK Gene Summary
The Nemo Like Kinase (NLK) gene is located on chr17 :26369687-26523404 at 17q11.2.
Gene Name: Nemo Like Kinase
Chromosome: CHR17: 26369687 -26523404
Locus: 17q11.2
Gene Diseases
The TADA2A NLK Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|